What should procurement teams budget for lifecycle costs when entering the Radiotherapy Market?

Service contracts, software subscriptions, and physics staffing typically add 55–70% to initial capital outlay across a ten-year horizon. Vendors increasingly bundle uptime guarantees into multi-year agreements priced per treatment room [19]. Read More

How do proton and photon systems compare on daily patient throughput?

Single-room proton units treat roughly 20–25 patients per day against 35–45 for a modern photon vault. Faster gantry rotation and automated positioning are narrowing that gap [12]. Read More

Which certifications matter most when qualifying vendors in the Radiotherapy Market?

IEC 60601-2-1 accelerator safety compliance and ISO 13485 quality certification are baseline requirements. European buyers additionally require Medical Device Regulation conformity, which extends launch timelines by nine to fifteen months [8]. Read More

Can existing bunkers be reused when upgrading accelerators?

Most vaults built after 2005 accept modern linacs with minor shielding modification, saving USD 1.2–1.8 million per room. Older bunkers frequently fail neutron shielding checks for high-energy configurations [22]. Read More

What role do managed-equipment services play in the Radiotherapy Market?

They convert capital spending into operating budget, letting public hospitals add capacity without upfront borrowing. Contracts typically run eight to twelve years and bundle refresh cycles, insurance, and applications training [17]. Read More

How exposed is the supply chain to isotope disruption?

Lutetium-177 and actinium-225 depend on a handful of reactors and accelerator facilities worldwide. A single outage can delay patient dosing by weeks, so dual-source contracting is now standard practice [6]. Read More

What staffing constraints limit new installations?

Each additional treatment vault requires roughly two medical physicists and six therapists. Training pipelines in emerging economies graduate far fewer specialists than installation plans demand, pushing commissioning past twelve months [4]. Read More

Radiotherapy Market (2026 - 2035)

ID: MRFR/HC/0997-HCR 200 Pages Nidhi Mandole Last Updated: September 15, 2026

Radiotherapy Market Research Report Size, Share, Trend Analysis By Technology (External Beam Radiotherapy, Brachytherapy, Systemic Radiotherapy, Intensity-Modulated Radiation Therapy, Stereotactic Radiosurgery), By Applications (Oncology, Palliative Care, Preoperative, Postoperative, Curative Treatment), By End Use (Hospitals, Cancer Research Centers, Outpatient Facilities), By Treatment Type (Conventional Radiotherapy, Radiotherapy for Targeted Therapy, Combination Therapy) and By Region (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

Radiotherapy Market

Market Size

Forecast Period2026-2035

CAGR (2026-2035)7.6%

2025 Market SizeUSD 9.09 Billion

2035 Market SizeUSD 18.91 Billion

Key Players

Siemens Healthineers

Elekta AB

Accuray Incorporated

Ion Beam Applications SA

Hitachi Ltd.

Brainlab AG

Trends

Cancer Incidence and the Treatment-Capacity Gap
Artificial Intelligence in Treatment Planning
Outpatient Reimbursement and Hypofractionation

Opportunities

Software-Defined Capacity Expansion
Emerging-Market Fleet Buildout
Radioligand Therapy Commercialisation

Summary Table of Contents Segmentation Methodology Download PDF

1 Market Summary |
1. 1.1 Study Assumptions & Market Definition |
2. 1.2 Scope of the Study |
3. 1.3 Research Methodology
2 Key Report Takeaways |
1. 2.1 By Technology |
2. 2.2 By Sector |
3. 2.3 By Region
3 Market Size & Forecast (2021–2035) |
1. 3.1 Historical Market Size (2021–2025) |
2. 3.2 Current & Forecast Market Size (2026–2035) |
3. 3.3 Year-over-Year Growth Analysis
4 Driver Impact Analysis |
1. 4.1 Cancer Incidence and the Treatment-Capacity Gap |
2. 4.2 Artificial Intelligence in Treatment Planning |
3. 4.3 Outpatient Reimbursement and Hypofractionation |
4. 4.4 Public Cancer Plans Across Asia-Pacific
5 Restraints Impact Analysis |
1. 5.1 Financing Costs and Deferred Capital Projects |
2. 5.2 Workforce Scarcity |
3. 5.3 Isotope Supply Concentration
6 Opportunities |
1. 6.1 Software-Defined Capacity Expansion |
2. 6.2 Emerging-Market Fleet Buildout |
3. 6.3 Radioligand Therapy Commercialisation |
4. 6.4 Outcomes Data Monetisation |
5. 6.5 Compact Particle Systems
7 Regional Market Share & Country-Level Analysis |
1. 7.1 North America | |
  1. 7.1.1 US | |
  2. 7.1.2 Canada | |
  3. 7.1.3 Mexico |
2. 7.2 Europe | |
  1. 7.2.1 Germany | |
  2. 7.2.2 UK | |
  3. 7.2.3 France | |
  4. 7.2.4 Italy | |
  5. 7.2.5 Spain | |
  6. 7.2.6 Nordic Countries | |
  7. 7.2.7 Russia | |
  8. 7.2.8 Rest of Europe |
3. 7.3 Asia-Pacific | |
  1. 7.3.1 China | |
  2. 7.3.2 India | |
  3. 7.3.3 Japan | |
  4. 7.3.4 South Korea | |
  5. 7.3.5 ASEAN | |
  6. 7.3.6 Rest of Asia-Pacific |
4. 7.4 South America | |
  1. 7.4.1 Brazil | |
  2. 7.4.2 Argentina | |
  3. 7.4.3 Rest of South America |
5. 7.5 Middle East & Africa | |
  1. 7.5.1 Saudi Arabia | |
  2. 7.5.2 UAE | |
  3. 7.5.3 South Africa | |
  4. 7.5.4 Egypt | |
  5. 7.5.5 Rest of Middle East & Africa
8 Future Outlook (2026–2035) |
1. 8.1 Autonomous Treatment Workflows |
2. 8.2 Service Contracts as the Profit Engine |
3. 8.3 Convergence with Nuclear Medicine |
4. 8.4 Sustainability and Facility Energy Load
9 Market Segmentation Analysis |
1. 9.1 By Product | |
  1. 9.1.1 Radiotherapy Equipment | |
  2. 9.1.2 Radiotherapy Software | |
  3. 9.1.3 Radiotherapy Services |
2. 9.2 By Technology | |
  1. 9.2.1 Intensity-Modulated Radiotherapy (IMRT) | |
  2. 9.2.2 Image-Guided Radiotherapy (IGRT) | |
  3. 9.2.3 3D Conformal Radiotherapy | |
  4. 9.2.4 Stereotactic Technology | |
  5. 9.2.5 Proton Beam Therapy | |
  6. 9.2.6 Volumetric Modulated Arc Therapy | |
  7. 9.2.7 Other Technologies |
3. 9.3 By Therapy Type | |
  1. 9.3.1 External Beam Radiation Therapy | |
  2. 9.3.2 Brachytherapy | |
  3. 9.3.3 Systemic Radiotherapy |
4. 9.4 By Application | |
  1. 9.4.1 Breast Cancer | |
  2. 9.4.2 Prostate Cancer | |
  3. 9.4.3 Lung Cancer | |
  4. 9.4.4 Head & Neck Cancer | |
  5. 9.4.5 Cervical Cancer | |
  6. 9.4.6 Colorectal Cancer | |
  7. 9.4.7 Other Applications |
5. 9.5 By End User | |
  1. 9.5.1 Hospitals and Clinics | |
  2. 9.5.2 Independent Radiotherapy Centres | |
  3. 9.5.3 Ambulatory Surgery Centres | |
  4. 9.5.4 Research Institutes
10 Competitive Landscape |
1. 10.1 Market Concentration Analysis (2026) |
2. 10.2 Competitive Benchmarking Matrix |
3. 10.3 Company Profiles | |
  1. 10.3.1 Siemens Healthineers (Varian) | |
  2. 10.3.2 Elekta AB | |
  3. 10.3.3 Accuray Incorporated | |
  4. 10.3.4 Ion Beam Applications SA | |
  5. 10.3.5 Hitachi Ltd. | |
  6. 10.3.6 Novartis AG | |
  7. 10.3.7 Brainlab AG | |
  8. 10.3.8 Lantheus Holdings | |
  9. 10.3.9 Sumitomo Heavy Industries | |
  10. 10.3.10 Mevion Medical Systems | |
  11. 10.3.11 Curium Pharma
11 Recent News & Developments
12 Report Scope & Methodology |
1. 12.1 Study Period & Base Year |
2. 12.2 Data Sources & Citations |
3. 12.3 Abbreviations
13 Detailed Sources & Citations
14 Frequently Asked Questions
15 LIST OF TABLES |
TABLE 1 Global Radiotherapy Market Size & Forecast, by Revenue (USD Billion), 2021–2035 |
TABLE 2 Global Radiotherapy Market – Year-over-Year Growth Analysis, 2021–2035 |
TABLE 3 Driver Impact Analysis – Contribution to CAGR, 2026–2035 |
TABLE 4 Restraint Impact Analysis – Drag on CAGR, 2026–2035 |
TABLE 5 Global Radiotherapy Market Size, by Region, 2021–2035 (USD Billion) |
TABLE 6 North America Radiotherapy Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 7 Europe Radiotherapy Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 8 Asia-Pacific Radiotherapy Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 9 South America Radiotherapy Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 10 Middle East & Africa Radiotherapy Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 11 Global Radiotherapy Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 12 Global Radiotherapy Market Size, by Technology, 2021–2035 (USD Billion) |
TABLE 13 Global Radiotherapy Market Size, by Therapy Type, 2021–2035 (USD Billion) |
TABLE 14 Global Radiotherapy Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 15 Global Radiotherapy Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 16 North America Radiotherapy Market Size, by Technology and End User, 2021–2035 (USD Billion) |
TABLE 17 Europe Radiotherapy Market Size, by Technology and End User, 2021–2035 (USD Billion) |
TABLE 18 Asia-Pacific Radiotherapy Market Size, by Technology and End User, 2021–2035 (USD Billion) |
TABLE 19 South America Radiotherapy Market Size, by Technology and End User, 2021–2035 (USD Billion) |
TABLE 20 Middle East & Africa Radiotherapy Market Size, by Technology and End User, 2021–2035 (USD Billion) |
TABLE 21 Competitive Benchmarking Matrix – Global Radiotherapy Market, 2026 |
TABLE 22 Company Profiles – Key Players, Global Radiotherapy Market |
TABLE 23 Recent Developments & Strategic Announcements, 2023–2025 |
TABLE 24 Report Scope & Methodology Summary |
TABLE 25 Detailed Sources & Citations Index
16 LIST OF FIGURES |
FIGURE 1 Global Radiotherapy Market – Market Dynamics Snapshot (Drivers, Restraints, Opportunities) |
FIGURE 2 Industry Value Chain Analysis – Component Supply to Clinical Delivery |
FIGURE 3 Porter's Five Forces Analysis – Global Radiotherapy Market |
FIGURE 4 Global Market Size Trend Line, 2021–2035 (USD Billion) |
FIGURE 5 Year-over-Year Growth Trajectory, 2022–2035 (%) |
FIGURE 6 Market Share by Product, 2025 vs 2035 (%) |
FIGURE 7 Market Share by Technology, 2025 (%) |
FIGURE 8 Market Share by Therapy Type, 2025 (%) |
FIGURE 9 Market Share by Application, 2025 (%) |
FIGURE 10 Market Share by End User, 2025 (%) |
FIGURE 11 Regional Revenue Share Distribution, 2025 (%) |
FIGURE 12 Regional CAGR Comparison, 2026–2035 (%) |
FIGURE 13 North America Country-Level Share Breakdown, 2025 (%) |
FIGURE 14 Europe Country-Level Share Breakdown, 2025 (%) |
FIGURE 15 Asia-Pacific Country-Level Share Breakdown, 2025 (%) |
FIGURE 16 Competitive Landscape – Estimated Revenue Share Bands, 2026 |
FIGURE 17 Competitive Positioning Matrix – Hardware vs Software Intensity |
FIGURE 18 Installed Accelerator Density per Million Population, by Region

Certified Researchers

Enquiry

Customize Report

Segmentation Quick Reference

Dimension	Sub-Segments	Dominant Segment	Fastest Growing Segment
By Product	Radiotherapy Equipment; Radiotherapy Software; Radiotherapy Services	Radiotherapy Equipment	Radiotherapy Software
By Technology	Intensity-Modulated Radiotherapy (IMRT); Image-Guided Radiotherapy (IGRT); 3D Conformal Radiotherapy; Stereotactic Technology; Proton Beam Therapy; Volumetric Modulated Arc Therapy; Other Technologies	Intensity-Modulated Radiotherapy (IMRT)	Proton Beam Therapy
By Therapy Type	External Beam Radiation Therapy; Brachytherapy; Systemic Radiotherapy	External Beam Radiation Therapy	Systemic Radiotherapy
By Application	Breast Cancer; Prostate Cancer; Lung Cancer; Head & Neck Cancer; Cervical Cancer; Colorectal Cancer; Other Applications	Breast Cancer	Lung Cancer
By End User	Hospitals and Clinics; Independent Radiotherapy Centres; Ambulatory Surgery Centres; Research Institutes	Hospitals and Clinics	Ambulatory Surgery Centres
By Region	North America; Europe; Asia-Pacific; South America; Middle East & Africa	North America	Asia-Pacific

Market Segmentation Overview

By Product

Sub-Segment	Key Trend
Radiotherapy Equipment	Replacement cycles overtake greenfield installs in mature health systems
Radiotherapy Software	Adaptive planning and auto-contouring shift revenue toward recurring licences
Radiotherapy Services	Multi-year uptime contracts become the primary margin pool for suppliers

Product mix is drifting away from one-time hardware sales. Departments buy capability upgrades that extend the useful life of vaults they already own, and suppliers are restructuring commercial models to match.

By Technology

Sub-Segment	Key Trend
Intensity-Modulated Radiotherapy (IMRT)	Remains default standard of care across most solid tumour protocols
Image-Guided Radiotherapy (IGRT)	Daily volumetric imaging enables tighter planning margins
3D Conformal Radiotherapy	Retains relevance in cost-constrained and high-volume public settings
Stereotactic Technology	Oligometastatic evidence expands curative-intent indications
Proton Beam Therapy	Compact single-room designs lower the facility cost threshold
Volumetric Modulated Arc Therapy	Shorter delivery times improve daily patient throughput
Other Technologies	Brachytherapy afterloaders and specialist platforms serve defined niches

Technology competition now runs through planning software as much as beam hardware. Vendors that make mixed-vendor fleets easier to manage gain influence over purchase decisions they do not directly supply.

By Therapy Type

Sub-Segment	Key Trend
External Beam Radiation Therapy	Hypofractionation lifts throughput per installed room
Brachytherapy	Guideline-mandated boost protocols sustain steady utilisation
Systemic Radiotherapy	Radioligand approvals draw pharmaceutical capital into the category

External beam retains overwhelming revenue weight, but systemic delivery is the structural story of the decade. Its growth pulls nuclear pharmacy logistics into the centre of oncology service planning.

By Application

Sub-Segment	Key Trend
Breast Cancer	Screening programmes and short-course regimens sustain volume leadership
Prostate Cancer	Aging demographics combine with hypofractionated and radioligand options
Lung Cancer	Stereotactic delivery converts inoperable cases to curative intent
Head & Neck Cancer	Complex anatomy sustains demand for highly modulated delivery
Cervical Cancer	Brachytherapy boost remains guideline standard in curative pathways
Colorectal Cancer	Neoadjuvant short-course protocols gain guideline traction
Other Applications	Sarcoma, lymphoma and palliative indications diversify caseload

Indication mix determines equipment mix. Centres with heavy thoracic and cranial caseloads justify stereotactic and image-guidance investment that high-volume breast programmes alone would not.

By End User

Sub-Segment	Key Trend
Hospitals and Clinics	Integrated pathways keep radiation adjacent to surgery and systemic therapy
Independent Radiotherapy Centres	Focused operations deliver shorter wait times and higher room utilisation
Ambulatory Surgery Centres	Site-neutral reimbursement removes the historic structural penalty
Research Institutes	Trial infrastructure drives early adoption of novel modalities

End-user structure is loosening as payment policy stops privileging hospital settings. Independent and ambulatory operators will absorb a growing share of routine, protocol-driven caseloads through 2035.

Certified Researchers

Enquiry

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”

Guilherme Gomes Martins Product Management Director

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”